32.51
-1.31 (-3.87%)
-1.31 (-3.87%)
Upgrade to Real-Time
Afterhours (Closed)
Best deals to access real time data! |
Big Cap Pro
Monthly Subscription
for only
|
Small Cap Basic
Monthly Subscription
for only
|
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
|
VAT not included
|
Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
Aptevo Therapeutics Inc | APVO | NASDAQ | Common Stock |
Price Change | Change Percent | Stock Price | Last Traded ![]() |
|
---|---|---|---|---|
-1.31 | -3.87% | 32.51 | 20:00:00 |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
33.59 | 32.4669 | 34.36 | 32.51 | 33.82 |
Bid Price | Ask Price | Spread | News | |
---|---|---|---|---|
32.00 | 35.35 | 3.35 | - | - |
Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
---|---|---|---|---|---|
2,222 | 73,344 | $ 33.67 | $ 2,469,763 | 98,118 | 0.195 - 60.00 |
Last Trade Time | Type | Quantity | Stock Price | Currency |
---|---|---|---|---|
19:18:26 | formt | 199 | $ 32.51 | USD |
Aptevo Therapeutics Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
$ 142.35M | 4.38M | 4.13M | $ 32.42M | $ - | -16.31 | -6.00 |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | $ - | 0.00% | 1.44M | 53.70% |
Aptevo Therapeutics News
Loading Messages....
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical APVO Price Data
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 36.57 | 37.5744 | 32.15 | 34.97 | 99,969 | -4.06 | -11.1% |
1 Month | 40.44 | 41.79 | 32.15 | 35.95 | 85,334 | -7.93 | -19.61% |
3 Months | 7.19 | 60.00 | 6.17 | 21.13 | 1,977,697 | 25.32 | 352.16% |
6 Months | 7.41 | 60.00 | 6.17 | 20.59 | 903,039 | 25.10 | 338.73% |
1 Year | 0.62 | 60.00 | 0.195 | 12.80 | 836,427 | 31.89 | 5,143.55% |
3 Years | 4.33 | 60.00 | 0.195 | 7.96 | 494,353 | 28.18 | 650.81% |
5 Years | 8.00 | 60.00 | 0.195 | 6.59 | 442,829 | 24.51 | 306.38% |
Aptevo Therapeutics Description
Aptevo Therapeutics Inc is a biosciences company. The company is engaged in the discovery, development, commercialization and sale of novel oncology and hematology therapeutics. Its pipeline product includes Otlertuzumab, APVO414, Multiple ADAPTIR Candidates, ALG.APV-527, APVO436 and APVO210. |